Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Shock. 2016 Jan;45(1):40–49. doi: 10.1097/SHK.0000000000000479

Figure 6. Anti-BTLA antibody treatment aggravated organs injury (24 hours) and increased mortality of Hem/CLP mice.

Figure 6

(A) Blunting and widening villus was observed in ileum with 6A6 treatment. (B) BALF protein concentration and serum creatine levels elevated significantly, but there is no change in serum ALT level (N=8 in H/C group, N=6 in Sham/sham group). The data are provided as the mean±SEM, and significant difference between groups is indicated as *P<0.05, by Bonferroni’s post-test following one-way ANOVA. (C) 6A6 treatment significantly increased the mortality of Hem/CLP mice (N=15/group). *P<0.05, Log-rank test.